Synthesis and In Vitro Neuroprotector Activity of Diastereoisomers of a Dimeric Dipeptide Mimetic of Nerve Growth Factor GK-2
- 作者: Sazonova N.M.1, Tarasyuk A.V.1, Shumskii A.N.1, Rebeko A.G.1, Antipov P.I.1, Logvinov I.O.1, Antipova T.A.1, Gudasheva T.A.1
- 
							隶属关系: 
							- V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
 
- 期: 卷 52, 编号 8 (2018)
- 页面: 704-710
- 栏目: Search for New Drugs
- URL: https://ogarev-online.ru/0091-150X/article/view/245421
- DOI: https://doi.org/10.1007/s11094-018-1885-3
- ID: 245421
如何引用文章
详细
Previously, a dimeric dipeptide mimetic bis-(N-monosuccinyl-L-glutamyl-L-lysine) hexamethylenediamide (GK-2) based on the β-turn of the fourth loop of nerve growth factor was prepared by us, activated TrkA, and exhibited neuroprotective activity in vitro (10–5 – 10–9 M) and in vivo (0.05 – 5 mg/kg i.p.). The present work reports the synthesis of two of its diastereomers, bis-(N-monosuccinyl-L-glutamyl-D-lysine) (GK-2LD) and bis-(N-monosuccinyl-D-glutamyl-L-lysine) hexamethylenediamides (GK-2DL). Studies of their neuroprotective activities using HT-22 neuronal culture under oxidative stress showed that switching L-lysine to D-lysine led to a significant activity decrease whereas switching L-glutamic acid to the D-stereoisomer caused it to disappear completely. Both dipeptide residues were concluded to be involved in interactions with the TrkA receptor.
关键词
作者简介
N. Sazonova
V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
							编辑信件的主要联系方式.
							Email: saz-nelly@mail.ru
				                					                																			                												                	俄罗斯联邦, 							8 Baltiiskaya, Moscow, 125315						
A. Tarasyuk
V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: saz-nelly@mail.ru
				                					                																			                												                	俄罗斯联邦, 							8 Baltiiskaya, Moscow, 125315						
A. Shumskii
V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: saz-nelly@mail.ru
				                					                																			                												                	俄罗斯联邦, 							8 Baltiiskaya, Moscow, 125315						
A. Rebeko
V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: saz-nelly@mail.ru
				                					                																			                												                	俄罗斯联邦, 							8 Baltiiskaya, Moscow, 125315						
P. Antipov
V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: saz-nelly@mail.ru
				                					                																			                												                	俄罗斯联邦, 							8 Baltiiskaya, Moscow, 125315						
I. Logvinov
V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: saz-nelly@mail.ru
				                					                																			                												                	俄罗斯联邦, 							8 Baltiiskaya, Moscow, 125315						
T. Antipova
V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: saz-nelly@mail.ru
				                					                																			                												                	俄罗斯联邦, 							8 Baltiiskaya, Moscow, 125315						
T. Gudasheva
V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: saz-nelly@mail.ru
				                					                																			                												                	俄罗斯联邦, 							8 Baltiiskaya, Moscow, 125315						
补充文件
 
				
			 
						 
						 
					 
						 
						 
				 
  
  
  
  
  电邮这篇文章
			电邮这篇文章  开放存取
		                                开放存取 ##reader.subscriptionAccessGranted##
						##reader.subscriptionAccessGranted## 订阅存取
		                                		                                        订阅存取
		                                					